Related Experiment Video
Updated: Jan 30, 2026

An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth
Takeshi Harada1, Shinji Matsumoto1, Suguru Hirota1
1Department of Molecular Biology and Biochemistry, Graduate School of Medicine, Osaka University, Osaka, Japan.
Abstract:
ADP-ribosylation factor-like 4c (ARL4C) is identified as a small GTP-binding protein, which is expressed by Wnt and EGF signaling and plays an important role in tubulogenesis of cultured cells and the ureters. ARL4C is little expressed in adult tissues, but it is highly expressed in lung cancer and colorectal cancer and shown to represent a molecular target for cancer therapy based on siRNA experiments. This study revealed that ARL4C is highly expressed in primary hepatocellular carcinoma (HCC) tumors and colorectal cancer liver metastases, and that ARL4C expression is associated with poor prognosis for these cancers. Chemically modified antisense oligonucleotides (ASO) against ARL4C effectively reduced ARL4C expression in both HCC and colorectal cancer cells and inhibited proliferation and migration of these cancer cells in vitro ARL4C ASOs decreased the PIK3CD mRNA levels and inhibited the activity of AKT in HCC cells, suggesting that the downstream signaling of ARL4C in HCC cells is different from that in lung and colon cancer cells. In addition, subcutaneous injection of ARL4C ASO was effective in reducing the growth of primary HCC and metastatic colorectal cancer in the liver of immunodeficient mice. ARL4C ASO accumulated in cancer cells more efficiently than the surrounding normal cells in the liver and decreased ARL4C expression in the tumor. These results suggest that ARL4C ASO represents a novel targeted nucleic acid medicine for the treatment of primary and metastatic liver cancers.
Insights
ADP-ribosylation factor-like 4c (ARL4C) is highly expressed in liver and colorectal cancers, driving tumor growth. Antisense oligonucleotides targeting ARL4C effectively inhibited cancer cell proliferation and tumor growth in preclinical models.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- ADP-ribosylation factor-like 4c (ARL4C) is a small GTP-binding protein.
- ARL4C expression is elevated in lung and colorectal cancers, suggesting its role as a therapeutic target.
- ARL4C is implicated in tubulogenesis and cellular processes regulated by Wnt and EGF signaling.
Purpose of the Study:
- To investigate the role of ARL4C in hepatocellular carcinoma (HCC) and colorectal cancer liver metastases.
- To evaluate the therapeutic potential of antisense oligonucleotides (ASO) targeting ARL4C.
- To elucidate the downstream signaling pathways affected by ARL4C in HCC.
Main Methods:
- Quantitative analysis of ARL4C expression in primary HCC and metastatic colorectal cancer tissues.
- In vitro studies using chemically modified ARL4C-targeting ASOs to assess effects on cancer cell proliferation and migration.
- In vivo studies involving subcutaneous injection of ARL4C ASO in immunodeficient mouse models of HCC and liver metastases.
Main Results:
- ARL4C is highly expressed in primary HCC and colorectal cancer liver metastases, correlating with poor prognosis.
- ARL4C ASOs significantly inhibited HCC and colorectal cancer cell proliferation and migration in vitro.
- ARL4C ASOs reduced PIK3CD mRNA levels and AKT activity in HCC cells, indicating pathway modulation.
- Subcutaneous ARL4C ASO administration suppressed tumor growth in vivo, with preferential accumulation in tumor cells.
Conclusions:
- ARL4C is a promising therapeutic target for primary and metastatic liver cancers.
- ARL4C ASO demonstrates efficacy in reducing tumor growth and proliferation in preclinical models.
- ARL4C ASO represents a potential novel targeted nucleic acid therapy for liver cancer.
Related Concept Videos
Primary and Secondary Growth in Roots and Shoots
Feedback Inhibition
Meristems and Plant Growth
Chemical Formulas
Chemical Equations
Enzyme Inhibition

